Renewal Fuels, Inc. (OTC: RNWF) Releases Independent Harbinger Research Report Evaluating Kepler Fusion's Texatron(TM) Platform GlobeNewswire January 06, 2026 SOUTHLAKE, Texas, Jan. 06, 2026 (GLOBE NEWSWIRE) — Renewal Fuels, Inc. (OTC: RNWF) (“RNWF” or the “Company”), together with Kepler Fusion Technologies Inc. (“Kepler”), today announced the publication and availability of independent research coverage by Harbinger […]

Nortech Systems Names Andrew Walko Senior Vice President of Global Operations GlobeNewswire January 06, 2026 MINNEAPOLIS, Jan. 06, 2026 (GLOBE NEWSWIRE) — Nortech Systems Incorporated (Nasdaq: NSYS) (“Nortech” or the “Company”), a leading provider of engineering and manufacturing solutions for complex electromedical and electromechanical products serving the medical imaging, medical device, industrial, and aerospace &

Syncromune Continues to Strengthen Executive and Clinical Leadership with Appointment of Dr. Stephen P. Dale, M.D., as Chief Medical Officer GlobeNewswire January 06, 2026 FORT LAUDERDALE, Fla. and WEST DES MOINES, Iowa, Jan. 06, 2026 (GLOBE NEWSWIRE) — Syncromune(R) Inc., a clinical-stage biopharmaceutical company dedicated to the development of SYNC-T(TM), an in situ platform combination

Hallador Energy Appoints Barbara Sugg, Former CEO of Southwest Power Pool, to Join Board of Directors GlobeNewswire January 06, 2026 TERRE HAUTE, Ind., Jan. 06, 2026 (GLOBE NEWSWIRE) — Hallador Energy Company (Nasdaq: HNRG) (“Hallador” or the “Company”) today announced that its Board of Directors (the “Board”) has appointed Barbara Sugg to the Board, effective

Roper Technologies schedules fourth quarter 2025 financial results conference call GlobeNewswire January 06, 2026 SARASOTA, Fla., Jan. 06, 2026 (GLOBE NEWSWIRE) — Roper Technologies, Inc. (Nasdaq: ROP) announced that its financial results for the fourth quarter of 2025, ended December 31, 2025, will be released before the market opens on Tuesday, January 27, 2026. A

SpyGlass Pharma Appoints Jean-Frederic Viret as Chief Financial Officer GlobeNewswire January 06, 2026 ALISO VIEJO, Calif., Jan. 06, 2026 (GLOBE NEWSWIRE) — SpyGlass Pharma(TM), a late-stage biopharmaceutical company, today announced the appointment of Jean-Frederic Viret, Ph.D., as the company's Chief Financial Officer (CFO). Dr. Viret brings over two decades of corporate finance experience in the

Erasca to Present at the 44th Annual J.P. Morgan Healthcare Conference GlobeNewswire January 06, 2026 SAN DIEGO, Jan. 06, 2026 (GLOBE NEWSWIRE) — Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers, today announced its participation in the 44th Annual J.P.

Earth Science Tech, Inc. (ETST) Issues Directive Industry Classification Update to SIC 2834; Formally Identifies as Pharmaceutical Entity Since 2022 GlobeNewswire January 06, 2026 MIAMI, FL, Jan. 06, 2026 (GLOBE NEWSWIRE) — Earth Science Tech, Inc. (OTC: ETST) (“ETST” or the “Company”), a strategic holding company, is issuing a formal directive to all financial data

Totus Medicines to Present at the 44th Annual J.P. Morgan Healthcare Conference GlobeNewswire January 06, 2026 15th Jan 2026 10:30 AM – 10:55 AM PST Elizabethan D – Private Company Track; Westin St. Francis Hotel, San Francisco, CA EMERYVILLE, Calif., Jan. 06, 2026 (GLOBE NEWSWIRE) — Totus Medicines, a clinical stage, precision medicines company leveraging

SAB BIO to Present at the 44th Annual J.P. Morgan Healthcare Conference GlobeNewswire January 06, 2026 MIAMI, Jan. 06, 2026 (GLOBE NEWSWIRE) — SAB Biotherapeutics, Inc. (Nasdaq: SABS), a clinical-stage biopharmaceutical company developing human anti-thymocyte immunoglobulin (hATG) for type 1 diabetes (T1D) and other autoimmune diseases, today announced that the Company's CEO Samuel J. Reich